Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 6.73013534 |
2 | RNA localization (GO:0006403) | 5.96217975 |
3 | signal complex assembly (GO:0007172) | 5.76926858 |
4 | heme biosynthetic process (GO:0006783) | 5.31915566 |
5 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.15650719 |
6 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.98451207 |
7 | megakaryocyte development (GO:0035855) | 4.85267524 |
8 | NADH metabolic process (GO:0006734) | 4.61394198 |
9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.58304068 |
10 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.55019451 |
11 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.33100686 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30143018 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30143018 |
14 | heme metabolic process (GO:0042168) | 4.19504174 |
15 | GDP-mannose metabolic process (GO:0019673) | 4.13505866 |
16 | pentose-phosphate shunt (GO:0006098) | 4.10190634 |
17 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 4.04453153 |
18 | response to pheromone (GO:0019236) | 4.03198738 |
19 | ribosomal small subunit assembly (GO:0000028) | 4.00306969 |
20 | tetrapyrrole biosynthetic process (GO:0033014) | 3.97008488 |
21 | viral transcription (GO:0019083) | 3.93522988 |
22 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.87389826 |
23 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.84747992 |
24 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.77189665 |
25 | regulation of necrotic cell death (GO:0010939) | 3.76211995 |
26 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.75565686 |
27 | maturation of 5.8S rRNA (GO:0000460) | 3.74071848 |
28 | translational termination (GO:0006415) | 3.70086029 |
29 | negative regulation of cell size (GO:0045792) | 3.65584370 |
30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61380367 |
31 | platelet formation (GO:0030220) | 3.60357739 |
32 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.60350450 |
33 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.60011267 |
34 | regulation of necroptotic process (GO:0060544) | 3.57007308 |
35 | glucose catabolic process (GO:0006007) | 3.54685057 |
36 | amino acid salvage (GO:0043102) | 3.51779578 |
37 | L-methionine salvage (GO:0071267) | 3.51779578 |
38 | L-methionine biosynthetic process (GO:0071265) | 3.51779578 |
39 | translational elongation (GO:0006414) | 3.50483597 |
40 | GMP metabolic process (GO:0046037) | 3.50143177 |
41 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.45397919 |
42 | porphyrin-containing compound metabolic process (GO:0006778) | 3.43322496 |
43 | NADPH regeneration (GO:0006740) | 3.42746375 |
44 | T cell apoptotic process (GO:0070231) | 3.42432521 |
45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.34906625 |
46 | regulation of mitochondrial translation (GO:0070129) | 3.30945965 |
47 | protein insertion into membrane (GO:0051205) | 3.29238967 |
48 | pentose metabolic process (GO:0019321) | 3.23714362 |
49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.22211767 |
50 | spliceosomal complex assembly (GO:0000245) | 3.20614508 |
51 | protein targeting to ER (GO:0045047) | 3.20598372 |
52 | cotranslational protein targeting to membrane (GO:0006613) | 3.19270318 |
53 | protein-cofactor linkage (GO:0018065) | 3.16744269 |
54 | necroptotic process (GO:0070266) | 3.13635347 |
55 | S-adenosylmethionine metabolic process (GO:0046500) | 3.13494766 |
56 | rRNA modification (GO:0000154) | 3.13438989 |
57 | thymic T cell selection (GO:0045061) | 3.12515954 |
58 | erythrocyte development (GO:0048821) | 3.12196733 |
59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.09820418 |
60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08959326 |
61 | negative regulation of RNA splicing (GO:0033119) | 3.08713716 |
62 | lymphocyte apoptotic process (GO:0070227) | 3.07984395 |
63 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.06913969 |
64 | proline biosynthetic process (GO:0006561) | 3.06538710 |
65 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.02328382 |
66 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.01590759 |
67 | positive regulation of B cell differentiation (GO:0045579) | 3.01410347 |
68 | protein localization to endoplasmic reticulum (GO:0070972) | 3.01367244 |
69 | positive regulation of macrophage differentiation (GO:0045651) | 3.00185570 |
70 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00107572 |
71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99189054 |
72 | iron-sulfur cluster assembly (GO:0016226) | 2.99044856 |
73 | metallo-sulfur cluster assembly (GO:0031163) | 2.99044856 |
74 | purine-containing compound salvage (GO:0043101) | 2.98416489 |
75 | cellular metabolic compound salvage (GO:0043094) | 2.96929945 |
76 | negative regulation of mRNA processing (GO:0050686) | 2.94868040 |
77 | erythrocyte maturation (GO:0043249) | 2.93262602 |
78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92986928 |
79 | glucose 6-phosphate metabolic process (GO:0051156) | 2.92398334 |
80 | cellular protein complex disassembly (GO:0043624) | 2.91486611 |
81 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.90924588 |
82 | positive regulation of T cell apoptotic process (GO:0070234) | 2.88467178 |
83 | regulation of B cell differentiation (GO:0045577) | 2.86931338 |
84 | ncRNA 3-end processing (GO:0043628) | 2.86706895 |
85 | ribosomal small subunit biogenesis (GO:0042274) | 2.85671995 |
86 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.85572988 |
87 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.85572988 |
88 | translational initiation (GO:0006413) | 2.84975724 |
89 | termination of RNA polymerase III transcription (GO:0006386) | 2.84790167 |
90 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84790167 |
91 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.84078203 |
92 | cytochrome complex assembly (GO:0017004) | 2.82574688 |
93 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.82076128 |
94 | peptidyl-histidine modification (GO:0018202) | 2.81511879 |
95 | oxaloacetate metabolic process (GO:0006107) | 2.79452328 |
96 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.78978543 |
97 | secretory granule organization (GO:0033363) | 2.78969381 |
98 | pseudouridine synthesis (GO:0001522) | 2.78480080 |
99 | snRNA transcription (GO:0009301) | 2.78337937 |
100 | regulation of skeletal muscle contraction (GO:0014819) | 2.77753611 |
101 | viral life cycle (GO:0019058) | 2.77637111 |
102 | T cell selection (GO:0045058) | 2.75802921 |
103 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.75380457 |
104 | DNA strand elongation (GO:0022616) | 2.73530867 |
105 | lipoxygenase pathway (GO:0019372) | 2.72846001 |
106 | leukocyte apoptotic process (GO:0071887) | 2.71429435 |
107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70420249 |
108 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.67332127 |
109 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.66654760 |
110 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.66134535 |
111 | viral mRNA export from host cell nucleus (GO:0046784) | 2.65805392 |
112 | methionine biosynthetic process (GO:0009086) | 2.65012888 |
113 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63952982 |
114 | spliceosomal snRNP assembly (GO:0000387) | 2.63516069 |
115 | programmed necrotic cell death (GO:0097300) | 2.63502702 |
116 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.63089737 |
117 | protein complex disassembly (GO:0043241) | 2.63029956 |
118 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.62959674 |
119 | regulation of translation in response to stress (GO:0043555) | 2.62958716 |
120 | NIK/NF-kappaB signaling (GO:0038061) | 2.62676789 |
121 | negative regulation of translational initiation (GO:0045947) | 2.60685044 |
122 | purine nucleotide salvage (GO:0032261) | 2.59619436 |
123 | tricarboxylic acid metabolic process (GO:0072350) | 2.59205290 |
124 | negative regulation of cell killing (GO:0031342) | 2.59071525 |
125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59071525 |
126 | mitotic G1/S transition checkpoint (GO:0044819) | 2.58840289 |
127 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.58402387 |
128 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.58072064 |
129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56523206 |
130 | * translation (GO:0006412) | 2.55849023 |
131 | regulation of superoxide anion generation (GO:0032928) | 2.55838341 |
132 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.55732047 |
133 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.55405353 |
134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.54896810 |
135 | rRNA methylation (GO:0031167) | 2.52335282 |
136 | UTP biosynthetic process (GO:0006228) | 2.52047301 |
137 | mannose metabolic process (GO:0006013) | 2.50637036 |
138 | cellular response to interferon-beta (GO:0035458) | 2.50162952 |
139 | macromolecular complex disassembly (GO:0032984) | 2.49223252 |
140 | response to misfolded protein (GO:0051788) | 2.48791469 |
141 | pigment biosynthetic process (GO:0046148) | 2.48098946 |
142 | B cell receptor signaling pathway (GO:0050853) | 2.48049415 |
143 | chaperone-mediated protein transport (GO:0072321) | 2.47121746 |
144 | deoxyribonucleotide catabolic process (GO:0009264) | 2.46595376 |
145 | L-serine metabolic process (GO:0006563) | 2.45726087 |
146 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.44914477 |
147 | negative regulation of ligase activity (GO:0051352) | 2.44914477 |
148 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230) | 2.44886246 |
149 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.43104493 |
150 | tetrapyrrole metabolic process (GO:0033013) | 2.43075398 |
151 | folic acid metabolic process (GO:0046655) | 2.43071418 |
152 | histone H2A acetylation (GO:0043968) | 2.42721187 |
153 | neutrophil activation involved in immune response (GO:0002283) | 2.42325115 |
154 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229) | 2.42309923 |
155 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.41163919 |
156 | nucleoside transmembrane transport (GO:1901642) | 2.40310626 |
157 | mitotic recombination (GO:0006312) | 2.39957738 |
158 | protein maturation by protein folding (GO:0022417) | 2.38486432 |
159 | GTP biosynthetic process (GO:0006183) | 2.35691961 |
160 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.35664742 |
161 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.35159677 |
162 | purine ribonucleotide transport (GO:0015868) | 2.33624439 |
163 | amyloid precursor protein catabolic process (GO:0042987) | 2.33598299 |
164 | base-excision repair, AP site formation (GO:0006285) | 2.32556935 |
165 | deoxyribose phosphate catabolic process (GO:0046386) | 2.32294185 |
166 | mitochondrial calcium ion transport (GO:0006851) | 2.31641173 |
167 | mitochondrial fusion (GO:0008053) | 2.31163217 |
168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30494620 |
169 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.29419960 |
170 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.28415010 |
171 | autophagic vacuole fusion (GO:0000046) | 2.26965332 |
172 | regulation of translational termination (GO:0006449) | 2.26903050 |
173 | cellular response to virus (GO:0098586) | 2.26797978 |
174 | response to food (GO:0032094) | 2.25640970 |
175 | positive thymic T cell selection (GO:0045059) | 2.25422681 |
176 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.24916957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.90189008 |
2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.50107893 |
3 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83617045 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.67582788 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 2.56806315 |
6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.42484966 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38843218 |
8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31908228 |
9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29728895 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27848772 |
11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14938658 |
12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.13966518 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.13754624 |
14 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.11568407 |
15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10128609 |
16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.08071136 |
17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02781982 |
18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.01893083 |
19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97643700 |
20 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.90977296 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86165589 |
22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.84875406 |
23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83874829 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82692932 |
25 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.82250792 |
26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81395437 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79877130 |
28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76785479 |
29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72902433 |
30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71249022 |
31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70856764 |
32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70389556 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66516574 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63850147 |
35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63763619 |
36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62593160 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61773484 |
38 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.60380286 |
39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59990125 |
40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57531391 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56781592 |
42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55284645 |
43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54346829 |
44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53625889 |
45 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.52431249 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51841831 |
47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.51611289 |
48 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.48438320 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47542213 |
50 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.47011377 |
51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46594826 |
52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46259801 |
53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45803544 |
54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44407147 |
55 | P68_20966046_ChIP-Seq_HELA_Human | 1.44307152 |
56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44085114 |
57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43032653 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.42919072 |
59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42502149 |
60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41775578 |
61 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.40858823 |
62 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40652750 |
63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39996695 |
64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37572207 |
65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37515029 |
66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37275131 |
67 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.36445707 |
68 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.36276572 |
69 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.36213877 |
70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33086470 |
71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32903804 |
72 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32667336 |
73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32451494 |
74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30952099 |
75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30936452 |
76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30218027 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29706141 |
78 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.29655695 |
79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29265032 |
80 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27606023 |
81 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.27404441 |
82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26630530 |
83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26252692 |
84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23205672 |
85 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23048511 |
86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22826535 |
87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22809759 |
88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22487180 |
89 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19328881 |
90 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18122177 |
91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18059252 |
92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17779810 |
93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17284229 |
94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17099224 |
95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17002371 |
96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16788509 |
97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16494773 |
98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16367800 |
99 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16225466 |
100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15891202 |
101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15712769 |
102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15503776 |
103 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15248804 |
104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15228172 |
105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15211405 |
106 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14225864 |
107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13685921 |
108 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13574883 |
109 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13480121 |
110 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12640578 |
111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11626952 |
112 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11576087 |
113 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10803023 |
114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09657078 |
115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08724807 |
116 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08586395 |
117 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.08529230 |
118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08292818 |
119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07961534 |
120 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07517923 |
121 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07245850 |
122 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07234601 |
123 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07120863 |
124 | MYB_26560356_Chip-Seq_TH1_Human | 1.07060010 |
125 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07058300 |
126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07016280 |
127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06997716 |
128 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06194979 |
129 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05950535 |
130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05344869 |
131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.03472600 |
132 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03197287 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003656_abnormal_erythrocyte_physiolo | 4.42009612 |
2 | MP0004147_increased_porphyrin_level | 4.26774249 |
3 | MP0005451_abnormal_body_composition | 4.18793305 |
4 | MP0005058_abnormal_lysosome_morphology | 2.90689885 |
5 | MP0002396_abnormal_hematopoietic_system | 2.70977228 |
6 | MP0004185_abnormal_adipocyte_glucose | 2.44824150 |
7 | MP0009840_abnormal_foam_cell | 2.44093185 |
8 | MP0001661_extended_life_span | 2.38612185 |
9 | MP0000685_abnormal_immune_system | 2.30952018 |
10 | MP0009333_abnormal_splenocyte_physiolog | 2.28041015 |
11 | MP0003806_abnormal_nucleotide_metabolis | 2.27182276 |
12 | MP0002132_abnormal_respiratory_system | 2.21513173 |
13 | MP0008260_abnormal_autophagy | 2.19963012 |
14 | MP0003693_abnormal_embryo_hatching | 2.17207502 |
15 | MP0003763_abnormal_thymus_physiology | 2.08918645 |
16 | MP0006036_abnormal_mitochondrial_physio | 2.07350207 |
17 | MP0005671_abnormal_response_to | 2.05896459 |
18 | MP0008058_abnormal_DNA_repair | 2.03383643 |
19 | MP0005075_abnormal_melanosome_morpholog | 1.99843863 |
20 | MP0003111_abnormal_nucleus_morphology | 1.95091743 |
21 | MP0004043_abnormal_pH_regulation | 1.90693013 |
22 | MP0002398_abnormal_bone_marrow | 1.88110562 |
23 | MP0000749_muscle_degeneration | 1.85192190 |
24 | MP0002722_abnormal_immune_system | 1.84267536 |
25 | MP0005083_abnormal_biliary_tract | 1.84050654 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.82168391 |
27 | MP0000689_abnormal_spleen_morphology | 1.75480801 |
28 | MP0004381_abnormal_hair_follicle | 1.72086417 |
29 | MP0000703_abnormal_thymus_morphology | 1.71447402 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.69198532 |
31 | MP0000678_abnormal_parathyroid_gland | 1.67386375 |
32 | MP0005360_urolithiasis | 1.66431877 |
33 | MP0004145_abnormal_muscle_electrophysio | 1.65820396 |
34 | MP0010155_abnormal_intestine_physiology | 1.62884971 |
35 | MP0005501_abnormal_skin_physiology | 1.62403158 |
36 | MP0002269_muscular_atrophy | 1.59871045 |
37 | MP0009278_abnormal_bone_marrow | 1.58710066 |
38 | MP0008007_abnormal_cellular_replicative | 1.58619041 |
39 | MP0001800_abnormal_humoral_immune | 1.57754995 |
40 | MP0004142_abnormal_muscle_tone | 1.57575007 |
41 | MP0003646_muscle_fatigue | 1.57353573 |
42 | MP0002429_abnormal_blood_cell | 1.55811960 |
43 | MP0000747_muscle_weakness | 1.54321211 |
44 | MP0010234_abnormal_vibrissa_follicle | 1.51233664 |
45 | MP0003172_abnormal_lysosome_physiology | 1.48445502 |
46 | MP0004957_abnormal_blastocyst_morpholog | 1.48050916 |
47 | MP0002419_abnormal_innate_immunity | 1.44235608 |
48 | MP0000858_altered_metastatic_potential | 1.43325273 |
49 | MP0000716_abnormal_immune_system | 1.38543560 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.37357220 |
51 | MP0001545_abnormal_hematopoietic_system | 1.37357220 |
52 | MP0001873_stomach_inflammation | 1.36270899 |
53 | MP0002420_abnormal_adaptive_immunity | 1.35379173 |
54 | MP0003303_peritoneal_inflammation | 1.35210072 |
55 | MP0001845_abnormal_inflammatory_respons | 1.32185100 |
56 | MP0001819_abnormal_immune_cell | 1.32175868 |
57 | MP0004858_abnormal_nervous_system | 1.31334054 |
58 | MP0002970_abnormal_white_adipose | 1.30886733 |
59 | MP0003137_abnormal_impulse_conducting | 1.30521434 |
60 | MP0005220_abnormal_exocrine_pancreas | 1.28297213 |
61 | MP0001533_abnormal_skeleton_physiology | 1.28276292 |
62 | MP0003077_abnormal_cell_cycle | 1.28147907 |
63 | MP0001764_abnormal_homeostasis | 1.28084907 |
64 | MP0005310_abnormal_salivary_gland | 1.27868892 |
65 | MP0005330_cardiomyopathy | 1.24407192 |
66 | MP0010094_abnormal_chromosome_stability | 1.24321783 |
67 | MP0001986_abnormal_taste_sensitivity | 1.24318317 |
68 | MP0002723_abnormal_immune_serum | 1.23801531 |
69 | MP0003866_abnormal_defecation | 1.19732050 |
70 | MP0000759_abnormal_skeletal_muscle | 1.19395244 |
71 | MP0005365_abnormal_bile_salt | 1.18171468 |
72 | MP0003436_decreased_susceptibility_to | 1.17488524 |
73 | MP0006035_abnormal_mitochondrial_morpho | 1.17054447 |
74 | MP0005636_abnormal_mineral_homeostasis | 1.14937220 |
75 | MP0002796_impaired_skin_barrier | 1.14726184 |
76 | MP0005410_abnormal_fertilization | 1.11444171 |
77 | MP0000750_abnormal_muscle_regeneration | 1.10795183 |
78 | MP0005387_immune_system_phenotype | 1.10774722 |
79 | MP0001790_abnormal_immune_system | 1.10774722 |
80 | MP0000751_myopathy | 1.10532685 |
81 | MP0004264_abnormal_extraembryonic_tissu | 1.10299104 |
82 | MP0009785_altered_susceptibility_to | 1.08135605 |
83 | MP0004947_skin_inflammation | 1.07373098 |
84 | MP0002452_abnormal_antigen_presenting | 1.05995472 |
85 | MP0001348_abnormal_lacrimal_gland | 1.05789367 |
86 | MP0003879_abnormal_hair_cell | 1.05687491 |
87 | MP0005025_abnormal_response_to | 1.04735498 |
88 | MP0003011_delayed_dark_adaptation | 1.03977423 |
89 | MP0003705_abnormal_hypodermis_morpholog | 1.03669387 |
90 | MP0002277_abnormal_respiratory_mucosa | 1.03559545 |
91 | MP0005000_abnormal_immune_tolerance | 1.02120674 |
92 | MP0004084_abnormal_cardiac_muscle | 1.01570380 |
93 | MP0010329_abnormal_lipoprotein_level | 1.01555626 |
94 | MP0005666_abnormal_adipose_tissue | 1.00963362 |
95 | MP0005464_abnormal_platelet_physiology | 1.00382997 |
96 | MP0003724_increased_susceptibility_to | 0.99940137 |
97 | MP0002019_abnormal_tumor_incidence | 0.99808382 |
98 | MP0002089_abnormal_postnatal_growth/wei | 0.99675163 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.98380465 |
100 | MP0000313_abnormal_cell_death | 0.97714419 |
101 | MP0006054_spinal_hemorrhage | 0.97404668 |
102 | MP0002106_abnormal_muscle_physiology | 0.97183447 |
103 | MP0009931_abnormal_skin_appearance | 0.95816276 |
104 | MP0009643_abnormal_urine_homeostasis | 0.95383216 |
105 | MP0004215_abnormal_myocardial_fiber | 0.93682003 |
106 | MP0000003_abnormal_adipose_tissue | 0.92604197 |
107 | MP0001216_abnormal_epidermal_layer | 0.92079922 |
108 | MP0004087_abnormal_muscle_fiber | 0.90938577 |
109 | MP0001849_ear_inflammation | 0.89701382 |
110 | MP0009764_decreased_sensitivity_to | 0.89650417 |
111 | MP0000609_abnormal_liver_physiology | 0.89491657 |
112 | MP0000598_abnormal_liver_morphology | 0.89245173 |
113 | MP0004233_abnormal_muscle_weight | 0.89228326 |
114 | MP0003315_abnormal_perineum_morphology | 0.88988131 |
115 | MP0005551_abnormal_eye_electrophysiolog | 0.88330874 |
116 | MP0005076_abnormal_cell_differentiation | 0.87887080 |
117 | MP0000358_abnormal_cell_content/ | 0.86809388 |
118 | MP0008569_lethality_at_weaning | 0.86503936 |
119 | MP0001727_abnormal_embryo_implantation | 0.85684584 |
120 | MP0002166_altered_tumor_susceptibility | 0.85215967 |
121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84909675 |
122 | MP0005670_abnormal_white_adipose | 0.84795543 |
123 | MP0005375_adipose_tissue_phenotype | 0.84679413 |
124 | MP0001835_abnormal_antigen_presentation | 0.84607079 |
125 | MP0002638_abnormal_pupillary_reflex | 0.84235257 |
126 | MP0002405_respiratory_system_inflammati | 0.83881526 |
127 | MP0010630_abnormal_cardiac_muscle | 0.82656911 |
128 | MP0000490_abnormal_crypts_of | 0.82374510 |
129 | MP0005332_abnormal_amino_acid | 0.82299871 |
130 | MP0005369_muscle_phenotype | 0.81501259 |
131 | MP0002822_catalepsy | 0.80887339 |
132 | MP0004130_abnormal_muscle_cell | 0.80676349 |
133 | MP0001730_embryonic_growth_arrest | 0.78433835 |
134 | MP0005319_abnormal_enzyme/_coenzyme | 0.77117544 |
135 | MP0002139_abnormal_hepatobiliary_system | 0.76482482 |
136 | MP0000681_abnormal_thyroid_gland | 0.75523434 |
137 | MP0001919_abnormal_reproductive_system | 0.75261226 |
138 | MP0008469_abnormal_protein_level | 0.74631319 |
139 | MP0004036_abnormal_muscle_relaxation | 0.74309901 |
140 | MP0001756_abnormal_urination | 0.74024947 |
141 | MP0006138_congestive_heart_failure | 0.73497107 |
142 | MP0009763_increased_sensitivity_to | 0.73253652 |
143 | MP0004782_abnormal_surfactant_physiolog | 0.72612642 |
144 | MP0000470_abnormal_stomach_morphology | 0.72561549 |
145 | MP0001663_abnormal_digestive_system | 0.72018635 |
146 | MP0003786_premature_aging | 0.69998779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.58175174 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 4.30877668 |
3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.92928477 |
4 | Petechiae (HP:0000967) | 3.25108433 |
5 | Myopathic facies (HP:0002058) | 3.25011013 |
6 | Microretrognathia (HP:0000308) | 3.03631660 |
7 | Panhypogammaglobulinemia (HP:0003139) | 3.00961339 |
8 | Congenital stationary night blindness (HP:0007642) | 2.99954932 |
9 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91271315 |
10 | Obstructive lung disease (HP:0006536) | 2.91271315 |
11 | Aplastic anemia (HP:0001915) | 2.88887436 |
12 | Eczematoid dermatitis (HP:0000976) | 2.87534986 |
13 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.86422772 |
14 | Prolonged neonatal jaundice (HP:0006579) | 2.85377069 |
15 | Hypertensive crisis (HP:0100735) | 2.84576923 |
16 | Cerebral hypomyelination (HP:0006808) | 2.81266379 |
17 | Hepatic necrosis (HP:0002605) | 2.80740253 |
18 | Increased serum ferritin (HP:0003281) | 2.76751309 |
19 | Reticulocytopenia (HP:0001896) | 2.71011880 |
20 | Poikilocytosis (HP:0004447) | 2.70471414 |
21 | Progressive muscle weakness (HP:0003323) | 2.69996363 |
22 | Hepatocellular necrosis (HP:0001404) | 2.66965544 |
23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65563353 |
24 | Macrocytic anemia (HP:0001972) | 2.61884105 |
25 | Abnormality of reticulocytes (HP:0004312) | 2.61710256 |
26 | Ragged-red muscle fibers (HP:0003200) | 2.59337085 |
27 | Reticulocytosis (HP:0001923) | 2.56478092 |
28 | Truncus arteriosus (HP:0001660) | 2.56009712 |
29 | Broad face (HP:0000283) | 2.55693880 |
30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53900295 |
31 | Rough bone trabeculation (HP:0100670) | 2.53349925 |
32 | Hypoglycemic coma (HP:0001325) | 2.51744061 |
33 | Premature ovarian failure (HP:0008209) | 2.51524772 |
34 | Cholelithiasis (HP:0001081) | 2.51367469 |
35 | IgM deficiency (HP:0002850) | 2.51098826 |
36 | Increased cerebral lipofuscin (HP:0011813) | 2.46376584 |
37 | Stridor (HP:0010307) | 2.46298276 |
38 | Recurrent bacterial skin infections (HP:0005406) | 2.44820289 |
39 | Abnormality of iron homeostasis (HP:0011031) | 2.44656707 |
40 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.44027654 |
41 | Pallor (HP:0000980) | 2.43200575 |
42 | Hyperthyroidism (HP:0000836) | 2.42176944 |
43 | Granulocytopenia (HP:0001913) | 2.40499734 |
44 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37727388 |
45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.37021474 |
46 | Concave nail (HP:0001598) | 2.36943941 |
47 | Abnormal gallbladder morphology (HP:0012437) | 2.36497218 |
48 | Pustule (HP:0200039) | 2.36405790 |
49 | Recurrent abscess formation (HP:0002722) | 2.36097224 |
50 | Muscle fiber inclusion bodies (HP:0100299) | 2.34805680 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.33941284 |
52 | Paralysis (HP:0003470) | 2.32800809 |
53 | Opisthotonus (HP:0002179) | 2.31462621 |
54 | Increased serum lactate (HP:0002151) | 2.29753246 |
55 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.28677387 |
56 | Abnormality of macrophages (HP:0004311) | 2.26809195 |
57 | Nemaline bodies (HP:0003798) | 2.26701488 |
58 | Hyperbilirubinemia (HP:0002904) | 2.24400553 |
59 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.22139659 |
60 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.22139659 |
61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21247982 |
62 | Increased muscle lipid content (HP:0009058) | 2.18941896 |
63 | Bulbar palsy (HP:0001283) | 2.18698256 |
64 | Annular pancreas (HP:0001734) | 2.18535728 |
65 | Severe combined immunodeficiency (HP:0004430) | 2.17449876 |
66 | Nonimmune hydrops fetalis (HP:0001790) | 2.16555861 |
67 | Abnormality of nail color (HP:0100643) | 2.15876115 |
68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13548892 |
69 | Combined immunodeficiency (HP:0005387) | 2.13433100 |
70 | Myositis (HP:0100614) | 2.13227423 |
71 | Mediastinal lymphadenopathy (HP:0100721) | 2.13226594 |
72 | Cerebral palsy (HP:0100021) | 2.12648767 |
73 | Increased IgE level (HP:0003212) | 2.12165987 |
74 | Microvesicular hepatic steatosis (HP:0001414) | 2.11172651 |
75 | Myoglobinuria (HP:0002913) | 2.10658646 |
76 | Exercise-induced myalgia (HP:0003738) | 2.10256346 |
77 | Recurrent viral infections (HP:0004429) | 2.09743284 |
78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.08008329 |
79 | Meningitis (HP:0001287) | 2.06969674 |
80 | Personality changes (HP:0000751) | 2.06464997 |
81 | Achilles tendon contracture (HP:0001771) | 2.05950160 |
82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05038153 |
83 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05038153 |
84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05038153 |
85 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.03042005 |
86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02173435 |
87 | Agammaglobulinemia (HP:0004432) | 2.02170106 |
88 | Rhabdomyolysis (HP:0003201) | 2.02025924 |
89 | Gastrointestinal inflammation (HP:0004386) | 2.00307391 |
90 | Neutropenia (HP:0001875) | 2.00238664 |
91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99388429 |
92 | Dicarboxylic aciduria (HP:0003215) | 1.99388429 |
93 | Abnormal trabecular bone morphology (HP:0100671) | 1.99034085 |
94 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98542743 |
95 | Calcaneovalgus deformity (HP:0001848) | 1.96940404 |
96 | Chronic otitis media (HP:0000389) | 1.95569184 |
97 | Abnormal hair laboratory examination (HP:0003328) | 1.94806532 |
98 | Hyperlipoproteinemia (HP:0010980) | 1.94029521 |
99 | Generalized hyperpigmentation (HP:0007440) | 1.93800146 |
100 | Hyperacusis (HP:0010780) | 1.93359655 |
101 | Gastrointestinal dysmotility (HP:0002579) | 1.93314987 |
102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92674623 |
103 | Ileus (HP:0002595) | 1.92586743 |
104 | Abnormality of the Achilles tendon (HP:0005109) | 1.92571208 |
105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92369300 |
106 | Septate vagina (HP:0001153) | 1.91353212 |
107 | Colitis (HP:0002583) | 1.91109127 |
108 | Trismus (HP:0000211) | 1.90183018 |
109 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.88977015 |
110 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.88977015 |
111 | Emotional lability (HP:0000712) | 1.86663978 |
112 | Encephalitis (HP:0002383) | 1.86636440 |
113 | Albinism (HP:0001022) | 1.86180938 |
114 | Dysostosis multiplex (HP:0000943) | 1.85987814 |
115 | Cortical visual impairment (HP:0100704) | 1.85794949 |
116 | Lactic acidosis (HP:0003128) | 1.85580115 |
117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84806656 |
118 | Abnormality of T cell physiology (HP:0011840) | 1.84457784 |
119 | Hemorrhage of the eye (HP:0011885) | 1.83842412 |
120 | Acute hepatic failure (HP:0006554) | 1.82986865 |
121 | Purpura (HP:0000979) | 1.82954715 |
122 | Recurrent fungal infections (HP:0002841) | 1.82163561 |
123 | Epistaxis (HP:0000421) | 1.81866382 |
124 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.80914191 |
125 | Ketoacidosis (HP:0001993) | 1.80587982 |
126 | Ketosis (HP:0001946) | 1.80176079 |
127 | Erythema (HP:0010783) | 1.79951041 |
128 | Ventricular tachycardia (HP:0004756) | 1.78985049 |
129 | Oral leukoplakia (HP:0002745) | 1.77853214 |
130 | Orchitis (HP:0100796) | 1.77795102 |
131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77677035 |
132 | Abnormality of T cells (HP:0002843) | 1.77150690 |
133 | Seborrheic dermatitis (HP:0001051) | 1.76937398 |
134 | Thrombocytosis (HP:0001894) | 1.76751341 |
135 | Recurrent skin infections (HP:0001581) | 1.76529143 |
136 | Pancytopenia (HP:0001876) | 1.76089645 |
137 | Squamous cell carcinoma (HP:0002860) | 1.75995673 |
138 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75456652 |
139 | Short femoral neck (HP:0100864) | 1.75281411 |
140 | Gastrointestinal stroma tumor (HP:0100723) | 1.75041824 |
141 | Testicular atrophy (HP:0000029) | 1.74329372 |
142 | Areflexia of lower limbs (HP:0002522) | 1.73688739 |
143 | Megaloblastic anemia (HP:0001889) | 1.73426340 |
144 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73356765 |
145 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73356765 |
146 | Abnormal blistering of the skin (HP:0008066) | 1.73230458 |
147 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73116037 |
148 | Mitochondrial inheritance (HP:0001427) | 1.72474677 |
149 | Prolonged bleeding time (HP:0003010) | 1.72347979 |
150 | Hypochromic anemia (HP:0001931) | 1.71205739 |
151 | Abnormality of eosinophils (HP:0001879) | 1.70902362 |
152 | Inflammation of the large intestine (HP:0002037) | 1.70900300 |
153 | Hypoparathyroidism (HP:0000829) | 1.70810131 |
154 | Progressive neurologic deterioration (HP:0002344) | 1.70352944 |
155 | Secondary amenorrhea (HP:0000869) | 1.69777716 |
156 | Cholecystitis (HP:0001082) | 1.69267079 |
157 | Abnormal gallbladder physiology (HP:0012438) | 1.69267079 |
158 | Urticaria (HP:0001025) | 1.67849418 |
159 | Hypercortisolism (HP:0001578) | 1.66534129 |
160 | Papilloma (HP:0012740) | 1.65812047 |
161 | Verrucae (HP:0200043) | 1.65812047 |
162 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.65715111 |
163 | Nail dystrophy (HP:0008404) | 1.65364991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 5.95844379 |
2 | RIPK1 | 5.47515212 |
3 | SMG1 | 3.04610019 |
4 | ERN1 | 2.91292069 |
5 | IRAK3 | 2.86609092 |
6 | MAP4K1 | 2.85062044 |
7 | STK16 | 2.68773819 |
8 | NEK1 | 2.45065861 |
9 | NME2 | 2.27615121 |
10 | BLK | 2.25200388 |
11 | KDR | 2.20247834 |
12 | TLK1 | 2.15564965 |
13 | TSSK6 | 2.15438753 |
14 | PIM2 | 1.98947689 |
15 | BCKDK | 1.97407500 |
16 | CAMKK2 | 1.94758862 |
17 | CDK19 | 1.88777920 |
18 | BUB1 | 1.86950900 |
19 | TESK2 | 1.85813289 |
20 | CAMK1D | 1.81504591 |
21 | EEF2K | 1.80968198 |
22 | SIK3 | 1.70758349 |
23 | INSRR | 1.69454192 |
24 | VRK2 | 1.67542084 |
25 | EIF2AK3 | 1.61413864 |
26 | IRAK4 | 1.53102691 |
27 | MAP3K10 | 1.49333094 |
28 | TRIB3 | 1.47709584 |
29 | MAPK15 | 1.46731315 |
30 | TBK1 | 1.43171432 |
31 | TNIK | 1.42915720 |
32 | NEK2 | 1.38068333 |
33 | MAP3K11 | 1.36751612 |
34 | TESK1 | 1.34490997 |
35 | BMPR2 | 1.33364985 |
36 | CAMK1G | 1.32384693 |
37 | TEC | 1.26138202 |
38 | SRPK1 | 1.18024349 |
39 | CDK12 | 1.11845793 |
40 | SIK1 | 1.11672014 |
41 | PINK1 | 1.10077200 |
42 | PRPF4B | 1.09608530 |
43 | TNK2 | 1.09529539 |
44 | MUSK | 1.08587826 |
45 | MAPK11 | 1.08057018 |
46 | RPS6KA4 | 1.07986138 |
47 | GRK1 | 1.07617250 |
48 | ZAP70 | 1.07392726 |
49 | SIK2 | 1.04613057 |
50 | BTK | 1.02022694 |
51 | SYK | 0.99230835 |
52 | TYK2 | 0.96256999 |
53 | ILK | 0.96134180 |
54 | PRKD2 | 0.95264987 |
55 | CCNB1 | 0.94914381 |
56 | BRSK1 | 0.94133116 |
57 | TAOK2 | 0.93058882 |
58 | PTK6 | 0.92977759 |
59 | IRAK2 | 0.92677674 |
60 | PKN2 | 0.92306271 |
61 | CAMK1 | 0.90589008 |
62 | FGFR4 | 0.89739090 |
63 | DYRK1B | 0.87426793 |
64 | MAP3K7 | 0.84869529 |
65 | BMX | 0.83218845 |
66 | FLT3 | 0.82273186 |
67 | MAP3K1 | 0.80593493 |
68 | TAOK3 | 0.78246304 |
69 | LIMK1 | 0.78208599 |
70 | BRAF | 0.77315802 |
71 | MAP3K3 | 0.76787300 |
72 | CDK4 | 0.75726835 |
73 | PIK3CG | 0.74441883 |
74 | IKBKE | 0.74043695 |
75 | CAMK4 | 0.73713993 |
76 | NME1 | 0.73388649 |
77 | VRK1 | 0.71956554 |
78 | GRK6 | 0.71873193 |
79 | TAOK1 | 0.71099450 |
80 | JAK3 | 0.70418299 |
81 | EIF2AK1 | 0.70149922 |
82 | CSK | 0.69713336 |
83 | WEE1 | 0.69448738 |
84 | TTN | 0.68097983 |
85 | ITK | 0.66104448 |
86 | ZAK | 0.66065128 |
87 | DYRK3 | 0.65451564 |
88 | MAPKAPK3 | 0.65018519 |
89 | ICK | 0.64564773 |
90 | MARK2 | 0.63448478 |
91 | * PDPK1 | 0.62519591 |
92 | OBSCN | 0.61185601 |
93 | DAPK1 | 0.60717955 |
94 | RAF1 | 0.59079572 |
95 | AKT2 | 0.57923468 |
96 | BRSK2 | 0.57594270 |
97 | MAP3K8 | 0.57571426 |
98 | ARAF | 0.57552796 |
99 | DAPK3 | 0.55512181 |
100 | CDK8 | 0.54306921 |
101 | HIPK2 | 0.54228125 |
102 | AURKA | 0.52776686 |
103 | RPS6KL1 | 0.52465971 |
104 | RPS6KC1 | 0.52465971 |
105 | * PRKCI | 0.52221151 |
106 | MAPK12 | 0.52035181 |
107 | TXK | 0.50053525 |
108 | RPS6KA5 | 0.49249747 |
109 | PAK4 | 0.47602720 |
110 | RPS6KA6 | 0.47218985 |
111 | KIT | 0.46887482 |
112 | PDK1 | 0.46763648 |
113 | LYN | 0.45908459 |
114 | CAMKK1 | 0.45903365 |
115 | MARK3 | 0.45775351 |
116 | EPHB1 | 0.44796709 |
117 | STK4 | 0.42332016 |
118 | MAP2K6 | 0.42167396 |
119 | MAPKAPK2 | 0.41851345 |
120 | RPS6KA2 | 0.41577199 |
121 | RPS6KB2 | 0.41404051 |
122 | HCK | 0.41051976 |
123 | PIM1 | 0.37865429 |
124 | CSF1R | 0.37363245 |
125 | MAP3K14 | 0.36090902 |
126 | ATR | 0.34773184 |
127 | ABL2 | 0.33725852 |
128 | MST1R | 0.33717477 |
129 | EPHA2 | 0.33701903 |
130 | PAK1 | 0.33494278 |
131 | MAPK7 | 0.32433965 |
132 | MAP2K3 | 0.32342754 |
133 | PRKG2 | 0.31480219 |
134 | IKBKB | 0.31011960 |
135 | MAP3K13 | 0.30756055 |
136 | MAP2K2 | 0.29518804 |
137 | LRRK2 | 0.29329380 |
138 | FES | 0.28830178 |
139 | STK38 | 0.28658733 |
140 | * MTOR | 0.26644574 |
141 | LCK | 0.26445992 |
142 | RIPK4 | 0.25944920 |
143 | CDK7 | 0.25497645 |
144 | CDC42BPA | 0.24779688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.60822239 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.23375414 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.15610799 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.03879611 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94096577 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.86343942 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.84435755 |
8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.72203330 |
9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.71385128 |
10 | Spliceosome_Homo sapiens_hsa03040 | 2.69341218 |
11 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.56863687 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.55789139 |
13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.25196721 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.16542310 |
15 | Base excision repair_Homo sapiens_hsa03410 | 2.05426831 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03718834 |
17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.99712176 |
18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94359552 |
19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.88440388 |
20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.86102924 |
21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63951820 |
22 | Homologous recombination_Homo sapiens_hsa03440 | 1.60710608 |
23 | Phototransduction_Homo sapiens_hsa04744 | 1.59551706 |
24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53144697 |
25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.52978349 |
26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52860435 |
27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50645994 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42979182 |
29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42717952 |
30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.40828327 |
31 | Purine metabolism_Homo sapiens_hsa00230 | 1.38254039 |
32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36897888 |
33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34904181 |
34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30109433 |
35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27372760 |
36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26918220 |
37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25057339 |
38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24775209 |
39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21575134 |
40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21496570 |
41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17632896 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17401888 |
43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16147565 |
44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14924628 |
45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14732590 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.14086086 |
47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.13901177 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11108816 |
49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09945334 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 1.07777222 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06609228 |
52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04431302 |
53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01884588 |
54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99802734 |
55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97359224 |
56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96883766 |
57 | RNA transport_Homo sapiens_hsa03013 | 0.96648376 |
58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94923948 |
59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94694221 |
60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.93485507 |
61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92600760 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91235287 |
63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91068954 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88907371 |
65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88547187 |
66 | Tuberculosis_Homo sapiens_hsa05152 | 0.88275288 |
67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87723379 |
68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86692174 |
69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86063355 |
70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85814916 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84690455 |
72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80043743 |
73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79347783 |
74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77516648 |
75 | Cell cycle_Homo sapiens_hsa04110 | 0.76824273 |
76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75484319 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74872893 |
78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74146887 |
79 | Allograft rejection_Homo sapiens_hsa05330 | 0.67952706 |
80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67926631 |
81 | Hepatitis B_Homo sapiens_hsa05161 | 0.66842609 |
82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65946237 |
83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65315564 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.65300207 |
85 | Influenza A_Homo sapiens_hsa05164 | 0.63969119 |
86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62219244 |
87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60981195 |
88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58421639 |
89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57889302 |
90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56629930 |
91 | Peroxisome_Homo sapiens_hsa04146 | 0.56579539 |
92 | * Insulin resistance_Homo sapiens_hsa04931 | 0.56214890 |
93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54172290 |
94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53943611 |
95 | RNA degradation_Homo sapiens_hsa03018 | 0.53894710 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52392441 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51837538 |
98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51692566 |
99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50593739 |
100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50354495 |
101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49470614 |
102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49205710 |
103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48907297 |
104 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48738740 |
105 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48182191 |
106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48121229 |
107 | Protein export_Homo sapiens_hsa03060 | 0.47870845 |
108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47842442 |
109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45934154 |
110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45852702 |
111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45242092 |
112 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44645992 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44159916 |
114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43734229 |
115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.43553289 |
116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42870249 |
117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42851815 |
118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42561152 |
119 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42385939 |
120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42000511 |
121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41630750 |
122 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41381818 |
123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40498347 |
124 | Lysosome_Homo sapiens_hsa04142 | 0.39536665 |
125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39495141 |
126 | Shigellosis_Homo sapiens_hsa05131 | 0.36603424 |
127 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35580625 |
128 | Alcoholism_Homo sapiens_hsa05034 | 0.35316911 |
129 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34908382 |
130 | Endocytosis_Homo sapiens_hsa04144 | 0.34901520 |
131 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34412064 |
132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33981374 |
133 | Measles_Homo sapiens_hsa05162 | 0.33973611 |
134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32641848 |
135 | Bile secretion_Homo sapiens_hsa04976 | 0.32608103 |
136 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32470214 |
137 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32029016 |
138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.30539467 |
139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30123748 |
140 | Bladder cancer_Homo sapiens_hsa05219 | 0.29365982 |
141 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27062482 |
142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26029035 |
143 | Apoptosis_Homo sapiens_hsa04210 | 0.23221972 |
144 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22922503 |
145 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22835553 |
146 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20948544 |
147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20751607 |